TVTX

Quote

Short

News

Articles

Message Board

Travere Therapeutics Inc. (NASDAQ : TVTX ) News

Travere Therapeutics Inc. (NASDAQ: TVTX) News Releases

TVTX News Releases

June 04, 2026 10:09:00 am

Business Wire

Travere Therapeutics Presents Long-Term Open-Label Extension Data from the Phase 3 DUPLEX Study at the 63rd European Renal Association (ERA) 2026 Congress

June 03, 2026 02:15:03 pm

KlickAnalytics

Buy Recommendation Issued On TVTX By Citigroup

June 02, 2026 04:10:00 pm

Investing News Network

5 Biggest Biotechnology ETFs in 2026

June 02, 2026 11:32:14 am

SeekingAlpha

Travere Therapeutics, Inc. (TVTX) Discusses Exclusive Licensing and Collaboration Agreement for Seborbrutinib with Everest Medicines Transcript

June 02, 2026 08:07:58 am

SeekingAlpha

Travere inks licensing deal worth up to $1.1B with China's Everest Medicines

June 02, 2026 07:01:00 am

Business Wire

Travere Therapeutics Enters Into Exclusive Licensing Agreement with Everest Medicines for Civorebrutinib a Potential Best-in-Class BTK Inhibitor for Rare Kidney Diseases

May 27, 2026 04:05:00 pm

Business Wire

Travere Therapeutics Receives Notice of Allowance from the U.S. Patent and Trademark Office for U.S. Patent Application Directed to Certain Methods of Using FILSPARI® (sparsentan) in IgA Nephropathy

May 24, 2026 04:13:22 pm

SeekingAlpha

SA Asks: What are the most attractive biotech stocks right now?

May 24, 2026 09:28:51 am

SeekingAlpha

AstraZeneca: 8% Q1 Revenue Growth And Imfinzi/Ultomiris Trial Data Wins

May 13, 2026 07:30:45 pm

SeekingAlpha

Travere Therapeutics, Inc. (TVTX) Presents at Bank of America Global Healthcare Conference 2026 Transcript

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account